MXC.AX Current Ratio

As of 2025-05-25, the Current Ratio of MGC Pharmaceuticals Ltd (MXC.AX) is 0.19.

Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.

MXC.AX Current Ratio - Historical Value

Date	Value
2023-06-30	0.19
2022-06-30	0.84
2021-06-30	1.55
2020-06-30	1.09
2019-06-30	1.71
2018-06-30	1.59
2017-06-30	2.51
2016-06-30	1.96
2015-06-30	1.31
2014-06-30	2.87

MXC.AX Current Ratio - Peers Comparison

Ticker	Name	Value
052670.KQ	Cheil Bio Co Ltd	13.22
239.HK	Pak Fah Yeow International Ltd	16.24
42C.SI	IX Biopharma Ltd	0.89
4596.T	Kubota Pharmaceutical Holdings Co Ltd	10.12
524774.BO	Ngl Fine Chem Ltd	2.64
AC8.AX	Auscann Group Holdings Ltd	49.47
ACR.AX	Acrux Ltd	4.14
AGH.AX	Althea Group Holdings Ltd	0.64
ANP.AX	Antisense Therapeutics Ltd	4.51
AVE.AX	Avecho Biotechnology Ltd	2.81
BOT.AX	Botanix Pharmaceuticals Ltd	22.21
CAN.AX	Cann Group Ltd	0.21
CGB.AX	Cann Global Ltd	2.95
ECS.AX	ECS Botanics Holdings Ltd	5.07
IHL.AX	Incannex Healthcare Ltd	9.02
LGP.AX	Little Green Pharma Ltd	3.34
MYX.AX	Mayne Pharma Group Ltd	1.47
NXGN.TA	Nextgen Biomed Ltd	0.08
NYR.AX	Nyrada Inc	25.35
PAA.AX	Neurizon Therapeutics Ltd	12.42
PBP.AX	Probiotec Ltd	0.81
RCE.AX	Recce Pharmaceuticals Ltd	0.34
RNO.AX	Rhinomed Ltd	0.27
TKUN.TA	Tikun Olam Cannbit Pharmaceuticals Ltd	0.32
VLS.AX	Vita Life Sciences Ltd	3.06
ZLD.AX	Zelira Therapeutics Ltd	0.6